The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
Clinical trial NCT06637527 · TERMINATED
Trial details
- NCT number
- NCT06637527
- Sponsor
- Okyo Pharma Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2025-04-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.